199 related articles for article (PubMed ID: 30467244)
21. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
22. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
23. Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.
Pachouri SS; Sobti RC; Kaur P; Singh J
DNA Cell Biol; 2007 Mar; 26(3):186-91. PubMed ID: 17417947
[TBL] [Abstract][Full Text] [Related]
24. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
25. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
27. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
28. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
[TBL] [Abstract][Full Text] [Related]
29. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
32. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
[TBL] [Abstract][Full Text] [Related]
33. Association of XRCC1 Arg399GIn and Tp53 Arg72Pro polymorphisms and increased risk of uterine leiomyoma - A case-control study.
Yaghmaei M; Salimi S; Namazi L; Farajian-Mashhadi F
Genet Mol Biol; 2015 Dec; 38(4):444-9. PubMed ID: 26692154
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population.
Zhang Z; Wan J; Jin X; Jin T; Shen H; Lu D; Xia Z
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2614-9. PubMed ID: 16284386
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
36. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
37. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients.
Nairuz T; Bushra YU; Kabir Y
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3809-3815. PubMed ID: 34967559
[TBL] [Abstract][Full Text] [Related]
38. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
[TBL] [Abstract][Full Text] [Related]
39. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
40. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
